Bone morphogenetic proteins: An update on basic biology and clinical relevance

Journal of Orthopaedic Research

Volumn 17, Issue 2, 1999, Pages 269-278

  Schmitt, John M ^a   Hwang, Kun ^a   Winn, Shelley R ^a   Hollinger, Jeffrey O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CARTILAGE; CELLS; GROWTH KINETICS; PROTEINS;

BONE MORPHOGENETIC PROTEINS; CELL GROWTH; OSTEOBLAST DIFFERENTIATION;

BONE;

BONE MORPHOGENETIC PROTEIN;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; FRACTURE HEALING; HUMAN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; DISEASE MODELS, ANIMAL; FRACTURE HEALING; GENE EXPRESSION REGULATION; HUMANS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 0032955419     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170217     Document Type: Review

References (123)

1. Amedee J, Bareille R, Rouais E, Cunningham N, Reddi H, Harmand MF: Osteogenin (bone morphogenetic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. Differentiation 58:157-164, 1994
2. Baker JC, Haland RM: From receptor to nucleus: the Smad pathway. Curr Opin Genet Dev 7:467-473, 1997
3. Boden SD: Bone growth enhancing substances for spinal fusion. In: Orthopaedic Knowledge Update. Spine, pp 63-70. Ed by SR Garfin and SR Vaccaro, Rosemont, Illinois, American Academy of Orthopaedic Surgeons, 1997
4. Bostrom MPG, Lane JM, Berberian WS, Missri AAE, Tomin E, Weiland A, Doty SB, Glaser D, Rosen VM: Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing. J Orthop Res 13:357-367, 1995
5. Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P: A feasibility study evaluation rhBMP-2/absorbable collagen sponge for maxillary sinus augmentation. Int J Periodont Restor Dent 17:11-25, 1997
6. Brighton CT, Hunt RM: Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg [Am] 73:832-847, 1991
7. Brighton CT, Lorich DG, Kupcha R, Reilly TM, Jones AR, Woodbury RA: The pericyte as a possible osteoblast progenitor cell. Clin Orthop 275:287-299, 1992
8. Bruder SP, Fink DJ, Caplan AI: Mesenchytnal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283-294, 1994
9. Brunet LJ, McMahon JA, McMahon AP, Harland RM: Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280:1455-1457, 1998
10. Caplan AI: Mesenchymal stem cells. J Orthop Res 9:641-650, 1991
11. Carcamo J, Weis FM, Ventura E, Wieser R, Wrana J, Attisano L, Massagué J: Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol 14:3810-3821, 1994
12. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM: Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 87:9843-9847, 1990
13. Celeste AJ, Taylor R, Yamaji N, Wang E, Ross J, Wozney J: Molecular cloning of BMP-8: present in bovine bone which is highly related to BMP-5/6/7 subfamily of osteoinductive molecules [abstract]. Presented at a symposium held at Keystone, Colorado, 1992
14. Celeste AJ, Song JJ, Cox K, Rosen V, Wozney JM: Bone morphogenetic protein-9, a new member of the TGF-beta superfamily. J Bone Miner Res 9:S137, 1994
15. Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R: A WD-domain protein that is associated with and phosphorylated by the tvpe II TGF-β receptor. Nature 377:548-552, 1995
16. Chen X, Rubock MJ, Whitman M: A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383:691-696, 1996
17. Clark RAF: The Molecular and Cellular Biology of Wound Repair. New York, Plenum Press, 1996
18. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC: Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 301:302-312, 1994
19. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud TS: The effect of human recombinant osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg [Am] 76:827-838, 1994
20. Cook SD, Dalton JE, Tan EH, Whitecloud TS 3rd, Rueger DC: In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19:1655-1663, 1994
21. Cook SD, Salkeld SL, Rueger DC: Evaluation of recombinant human osteogenic protein (rhOP-1) placed with dental implants in fresh extraction sites. J Oral Implantai 21:281-289, 1995
22. Cook SD, Wolfe MW, Salkeld SL, Rueger DC: Effect of recombinant human osteogenic protein-1 on healing of segmentai defects in non-human primates. J Bone Joint Surg [Am] 77:734-750, 1995
23. Ducy P, Karsenty G: Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869, 1995
24. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 89:747-754, 1997
25. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807, 1995
26. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L: MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552, 1996
27. Geoffroy V, Ducy P, Karsenty G: A PEBP2α/AML-1-related factor increases osteocalcin promoter activity through its binding to a osteoblast-specific cis-acting element. J Biol Chem 270:30973-30979, 1995
28. Griffiths AJF, Miller J, Suzuki D, Lewontin R, Gelbart W: An Introduction to Genetic Analysis, 6th ed, pp 564-573. New York, W. H. Freeman, 1996
29. Hartsough MT, Frey RS, Zipfel PA, Buard A, Cook SJ, McCormick F, Mulder KM: Altered transforming growth factor signaling in epithelial cells when ras activation is blocked. J Biol Chem 271:22368-22375, 1996
30. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12:186-197, 1998
31. Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
32. Hogan BL: Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432-438, 1996
33. Hollinger J, Wong ME: The integrated processes of hard tissue regeneration with special emphasis on fracture healing. Oral Surg Oral Med Oral Path Oral Radiol Endodontics 82:594-606, 1996
34. Hollinger JO: Factors for osseous repair and delivery. Part 1. J Craniofac Surg 4:102-108, 1993
35. Hollinger JO, Leong K: Poly(alpha-hydroxy acids): carriers for bone morphogenetic proteins. Biomaterials 17:187-194, 1996
36. Hollinger JO, Mayer M, Buck D, Zegzula HD, Ron E, Smith J, Lin L, Wozney J: Poly(alpha-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. J Controlled Rel 39:287-304, 1996
37. Hollinger JO, Buck DC, Bruder S: Biology of bone healing: its impact on clinical therapy. In: Tissue Engineering Applications in Maxillofacial Surgery and Periodontics, pp 17-54. Carol Stream, Illinois, Quintessence Publishing, 1999
38. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana J: MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500, 1996
39. Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D: A feasibility study evaluating rhBMP-2/absorable collagen sponge device for local alveolar ridge preservation or augmentaion. Int J Periodontics Restorative Dent 17:124-139, 1997
40. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1:673-683, 1998
41. Hurley M, Florkiewicz R: Fibroblast growth factor and vascular endothelial cell growth factor families. In: Principles of Bone Biology, pp 627-646. Ed by JP Bilezikian, LG Raisz, and GA Rodan. San Diego, Academic Press, 1996
42. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K: Smado inhibits signalling by the TGF-β superfamily. Nature 389:622-626, 1997
43. Ito Y: Structural alterations in the transcription factor PEBP2/Cbf linked to four different types of leukemia. J Cancer Res Clin Oncol 122:266-274, 1996
44. Jaiswal N, Bruder SP: Human osteoblastic cells secrete paracrine factors which regulate differentiation of osteogenic precursors in marrow. Trans Orthop Res Soc 22:524, 1997
45. Kania MA, Bonner AS, Duffy JB, Gergen JP: The Drosophila segementation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev 4:1701-1713, 1990
46. Kaplan FS, Tabas JA, Zasloff MA: Fibrodysplasia ossificans progressive: a clue from the fly? Calcif Tissue Int 47:117-125, 1990
47. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A: Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388:304-308, 1997
48. Kingsley D: What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet 10:16-21, 1994
49. Kingsley DM, Bland AE, Grubber JM, Marker PC, Russell LB, Copeland NG, Jenkins NA: The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF-beta superfamily. Cell 71:399-410, 1992
50. Kingsley DM: The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146, 1994
51. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764, 1997
52. Kretzschmar M, Liu E, Hata A, Doody J, Massagué J: The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11:984-995, 1997
53. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J: Partnership between DCP4 and SMAD proteins in TGF-β signalling pathways. Nature 383:832-836, 1996
54. Liu F, Ventura F, Doody J, Massagué J: Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479-3486, 1995
55. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, Massagué J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-623, 1996
56. Lo RS, Chen YG, Shi Y, Pavletich NP, Massagué J: The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J 17:996-1005, 1998
57. Long MW, Robinson JA, Ashcraft EA, Mann KG: Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95:881-887, 1995
58. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G: BMP-7 is an inducer of neprogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820, 1995
59. Marden LJ, Hollinger JO, Chaudhari A, Turek T, Schaub RG, Ron E: Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rat. J Biomed Mater Res 28:1127-1138, 1994
60. Massagué J: The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641, 1990
61. Massagué J, Cheifetz S, Laiho M, Ralph DA, Weis FMB, Zente A: Transforming growth factor-β. Cancer Surv 12:81-103, 1992
62. Massagué J: TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85:947-950, 1996
63. Mayer MH, Hollinger JO, Ron E, Wozney J: Repair of alveolar clefts in dogs with recombinant bone morphogenetic protein and poly(α-hydroxy acid). Plast Reconstr Surg 98:247-259, 1996
64. Meyers S, Hiebert SW: Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Crit Rev Eukary Gene Express 5:365-383, 1995
65. Mishina Y, Suzuki A, Ueno N, Behringer RR: Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037, 1995
66. Mucsi I, Skorecki K, Goldberg HJ: Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-β1 on gene expression. J Biol Chem 271:16567-16572, 1996
67. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll J, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR: Mutations involving the transcription factor Cbfa1 cause cleidocranial dysplasia. Cell 89:773-779, 1997
68. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K: Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9:651-659, 1994
69. Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM: Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-β responsive cells. Development 122:2099-2108, 1996
70. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T: Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273:1872-1879, 1998
71. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K: Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352, 1996
72. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS: Identification of a human type II receptor for bone morphogenetic protine-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270:22522-22526, 1995
73. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K: Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194:314-331, 1993
74. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y: PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90:6859-6863, 1993
75. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, ten Dijke P, Sakou T: Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a bmp type II receptor during fracture healing in rats. Bone 22:605-612, 1998
76. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771, 1997
77. Owen M: The origin of bone cells in the postnatal organism. Arthritis Rheum 23:1073-1080, 1980
78. Owen M: Lineage ofOsteogenic Cells and their Relationship to the Stromal System, pp 1-25. Amsterdam, Elsevier Science, 1985
79. Özkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H: OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J 9:2085-2093, 1990
80. Özkaynak E, Schnegelsberg PN, Jin DF, Clifford GM, Warren ED, Drier EA, Oppermann H: Osteogenic protein-2: a new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. J Biol Chem 267:25220-25227, 1992
81. Rao VV, Loffler C, Wozney JM, Hansmann I: The gene for bone morphogenetic protein 2A (BMP2A) is localized to human chromosome 20p12 by radioactive and nonradioactive in situ hybridization. Hum Genet 90:299-302, 1992
82. Reddi AH, Ma SS, Cunningham NS: Induction and maintenance of new bone formation by growth and differentiation factors. Ann Chir Gynaecol 77:189-192, 1988
83. Reddi AH: Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 4:850-855, 1992
84. Reddi AH: Bone and cartilage differentiation. Curr Opin Genet Dev 4:737-744, 1994
85. Reddi AH: Bone and cartilage morphogenesis: cell biology to clinical applications. Curr Opin Genet Dev 4:737-744, 1994
86. Rickard DJ, Sullivan TA, Shenker BJ, LeBoy PS, Kazhdan I: Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218-228, 1994
87. Ripamonti U, van den Heever B, Sampath TK, Tucker MM, Rueger DC, Reddi AH: Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 13:273-289, 1996
88. Robinson D, Bab I, Nevo Z: Osteogenic growth peptide regulates proliferation and osteogenic maturation of human and rabbit bone marrow stromal cells. J Bone Miner Res 10:690-696, 1995
89. Rodan GA, Harada S: The missing bone. Cell 89:677-680, 1997
90. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K: Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636, 1995
91. Sakou T: Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22:591-603, 1998
92. Savage C, Das P, Finelli AL, Townsend SR, Sun CY, Baird SE, Padgett RW: Caenorhabditis elegans genes sma-2, sma-3, sma-4 define a conserved family of transforming growth factor beta pathway components. Proc Natl Acad Sci USA 93:790-794, 1996
93. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM: Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139:1347-1358, 1995
94. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS: Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561, 1996
95. Speck NA, Terryl S: A new transcription factor family associated with human leukemias. Crit Rev Eukary Gene Express 5:337-364, 1995
96. Tabas JA, Hahn GV, Cohen RB, Seaunez HN, Modi WS, Wozney JM, Zasloff M, Kaplan FS: Chromosomal assignment of the human gene for bone morphocenetic protein 4. Clin Orthop 293:310-316, 1993
97. Takagi K, Urist MR: The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 196:100-109, 1982
98. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA: Mandibular reconstruction with a recombinant bone-inducing factor: functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 117:1101-1112, 1991
99. Towler DA, Bennette CD, Rodan GA: Activity of the rat osteocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endocrinol 8:614-624, 1994
100. Urist MR: Bone: formation by autoinduction. Science 150:893-899, 1965
101. Urist MR, Strates BS: Bone morphogenetic protein. J Dent Res 50:1392-1406, 1971
102. Urist MR: Bone morphogenetic protein induced bone formation in experimental animals and patients with large bone defects. In: Cell and Molecular Biology of Vertebrate Hard Tissue, pp 281 -284. Ed by D Evered and S Harnett. Chichester. Wiley, 1988
103. Urist MR: Bone morphogenetic proteins in biology and medicine. In: Bone Morphogenetic Proteins: Biology, Biochemistry, and Reconstructive Surgery, pp 7-30. Ed by TS Lindholm. New York, Academic Press, 1996
104. Vaananen K: Osteoclast function: biology and mechanisms. In: Principles of Bone Biology, pp 103-113. Ed by JP Bilezikian, LG Raisz, and GA Rodan. San Diego, Academic Press, 1996
105. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos IK, Nove J, Wozney JM: Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220-2224, 1990
106. Wang EA: Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. Trends Biotech 11:379-383, 1993
107. Wang T, Danielson PD, Li BY, Shah PC, Kim SD, Donahoe PK: The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling. Science 271:1120-1122, 1996
108. Wang T, Li BY, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Manganaro T, Donahoe PK: The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86:435-444, 1996
109. Watanabe TK, Suzuki M, Omori Y, Hishigaki H, Horie M, Kanemoto N, Fujiwara T, Nakamura Y, Takahashi E: Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics 42:446-451, 1997
110. Wiersdorff V, Lecuit T, Cohen SM, Mlodzik M: Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development 122:2153-2162, 1996
111. Winn SR, Uludag H, Hollinger JO: Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31:303-318, 1998
112. Winn SR, Randolph G, Uludag H, Wong S, Hu Z, Hollinger JO: Establishing an immortalized human osteoprecursor cell line. Unpublished data
113. Winnier G, Blessing M, Labosky PA, Hogan BL: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116, 1995
114. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534, 1988
115. Wozney JM: Bone morphogenetic proteins and their expression. In: Cellular and Molecular Biology of Bone, pp 131-165. Ed by M Noda. San Francisco, Academic Press, 1993
116. Wrana JL, Attisano L, Wiesner R, Ventura E, Massagué J: Mechanism of activation of the TGF-β receptor. Nature 370:341-347, 1994
117. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011, 1995
118. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T: Smad1 and Smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574-580, 1997
119. Yamashita H, Ten Dijke P, Heldin CH, Miyazono K: Bone morphogenetic protein receptors. Bone 19:569-574, 1996
120. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2): a radiographie, histological, and biomechanical study in rats. J Bone Joint Surg [Am] 74:659-670, 1992
121. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO: Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg [Am] 79:1778-1790, 1997
122. Zhang H, Bradley A: Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986, 1994
123. Zimmerman LB, De Jesus-Escobar JM, Harland RM: The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606, 1996